South Korean firm to produce 150 mln doses a year of Russian COVID-19 vaccine - RDIF

South Korea's GL Rapha will make more than 150 million doses of Sputnik V coronavirus vaccine per year, Russia's sovereign wealth fund said on Friday, one of its biggest production deals announced so far as Moscow aims to boost output abroad.

Reuters | Seoul | Updated: 13-11-2020 16:09 IST | Created: 13-11-2020 15:41 IST
South Korean firm to produce 150 mln doses a year of Russian COVID-19 vaccine - RDIF
Representative image

South Korea's GL Rapha will make more than 150 million doses of Sputnik V coronavirus vaccine per year, Russia's sovereign wealth fund said on Friday, one of its biggest production deals announced so far as Moscow aims to boost output abroad. While Russia is ramping up its domestic production capacities, which will be focused on meeting its own needs, it has also reached agreements to produce 500 million doses annually abroad, which will supply other countries.

The South Korean deal marks a second production agreement since Russia said on Wednesday that the vaccine was found to be 92% effective at protecting people from COVID-19 according to interim trial results. Hours after the results were announced, China's Tibet Rhodiola Pharmaceutical Holding said a deal had been agreed to manufacture, sell and test Sputnik V vaccine in China.

The South Korean firm is expected to begin production next month, the Russian Direct Investment Fund (RDIF) said in a statement on Friday. The doses will be intended for global distribution, it said. GL Rapha has been in talks with RDIF head Kirill Dmitriev for several months this year after the sovereign fund approached it first, a spokesperson for the South Korean firm said.

Dmitriev had planned to visit the company, but the plan was put off due to the pandemic, the official said. The biotech company, founded in 2007, offers fill and finish of vials and oversees the whole process of vaccine production. RDIF, which is backing the vaccine's development and is responsible for its marketing abroad, said it had orders for more than 1.2 billion doses of Sputnik V.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

Philippines receives first batch of COVID-19 vaccine, doses donated by China

The Philippines received on Sunday its first batch of COVID-19 vaccine doses in a shipment donated by China, a day before it was due to roll out a national inoculation campaign.President Rodrigo Duterte attended a ceremony to mark the arriv...

Tennis-Popyrin fights back to win maiden ATP title in Singapore

Australias Alexei Popyrin stormed back from a set down to beat Alexander Bublik of Kazakhstan 4-6 6-0 6-2 and clinch his first ATP Tour title at the Singapore Open on Sunday. Popyrin fired 11 aces and broke serve five times to hand fourth s...

School students in India discover 18 new asteroids

The International Astronomical Union IAU, an organisation which assigns official names and designations to celestial bodies, has recently confirmed the discovery of 18 new asteroids by Indian students as part of a global science programme.T...

2 VCs resign in Maha, ABVP alleges government interference

Two vice chancellors of universities in Maharashtra have abruptly quit their posts before the end of their tenure and submitted their resignations to Governor Bhagat Singh Koshyari.While sources said the two VCs cited personal reasons for t...

Give Feedback